intertissue limited Company Information
Company Number
04537324
Website
http://sofidel.comRegistered Address
brunel way baglan energy park, briton ferry, neath, SA11 2FP
Industry
Manufacture of paper and paperboard
Telephone
01204673300
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
sofidel spa 100%
intertissue limited Estimated Valuation
Pomanda estimates the enterprise value of INTERTISSUE LIMITED at £0 based on a Turnover of £0 and 0.35x industry multiple (adjusted for size and gross margin).
intertissue limited Estimated Valuation
Pomanda estimates the enterprise value of INTERTISSUE LIMITED at £0 based on an EBITDA of £0 and a 2.79x industry multiple (adjusted for size and gross margin).
intertissue limited Estimated Valuation
Pomanda estimates the enterprise value of INTERTISSUE LIMITED at £452.1k based on Net Assets of £299k and 1.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Intertissue Limited Overview
Intertissue Limited is a live company located in neath, SA11 2FP with a Companies House number of 04537324. It operates in the manufacture of paper and paperboard sector, SIC Code 17120. Founded in September 2002, it's largest shareholder is sofidel spa with a 100% stake. Intertissue Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Intertissue Limited Health Check
There is insufficient data available to calculate a health check for Intertissue Limited. Company Health Check FAQs
![Health Check Image](/assets/images/big_heart.png)
![positive_score](/assets/images/scoreRate2.png)
0 Strong
![positive_score](/assets/images/scoreRate1.png)
0 Regular
![positive_score](/assets/images/scoreRate0.png)
0 Weak
![size](/assets/images/scoreRate-1.png)
Size
There is insufficient data available for this Key Performance Indicator!
- - Intertissue Limited
- - Industry AVG
![growth](/assets/images/scoreRate-1.png)
Growth
There is insufficient data available for this Key Performance Indicator!
- Intertissue Limited
- - Industry AVG
![production](/assets/images/scoreRate-1.png)
Production
There is insufficient data available for this Key Performance Indicator!
- Intertissue Limited
- - Industry AVG
![profitability](/assets/images/scoreRate-1.png)
Profitability
There is insufficient data available for this Key Performance Indicator!
- Intertissue Limited
- - Industry AVG
![employees](/assets/images/scoreRate-1.png)
Employees
There is insufficient data available for this Key Performance Indicator!
- - Intertissue Limited
- - Industry AVG
![paystructure](/assets/images/scoreRate-1.png)
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Intertissue Limited
- - Industry AVG
![efficiency](/assets/images/scoreRate-1.png)
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Intertissue Limited
- - Industry AVG
![debtordays](/assets/images/scoreRate-1.png)
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Intertissue Limited
- - Industry AVG
![creditordays](/assets/images/scoreRate-1.png)
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Intertissue Limited
- - Industry AVG
![stockdays](/assets/images/scoreRate-1.png)
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Intertissue Limited
- - Industry AVG
![cashbalance](/assets/images/scoreRate-1.png)
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Intertissue Limited
- - Industry AVG
![debtlevel](/assets/images/scoreRate-1.png)
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Intertissue Limited
- - Industry AVG
INTERTISSUE LIMITED financials
![ms excel logo](/assets/images/ms_excel_logo.png)
Intertissue Limited's latest turnover from December 2022 is estimated at 0 and the company has net assets of £299 thousand. According to their latest financial statements, we estimate that Intertissue Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0 | 59,071,000 | 128,889,000 | 131,903,000 | 133,628,000 | 130,654,000 | 149,412,000 | 150,501,000 | 94,580,657 | 126,683,056 | 99,901,358 | 87,806,319 | ||
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cost Of Sales | 0 | 46,365,000 | 98,068,000 | 102,909,000 | 105,234,000 | 104,033,000 | 122,076,000 | 121,404,000 | 79,609,259 | 89,760,354 | 64,567,890 | 56,624,265 | ||
Gross Profit | 0 | 12,706,000 | 30,821,000 | 28,994,000 | 28,394,000 | 26,621,000 | 27,336,000 | 29,097,000 | 14,971,398 | 36,922,702 | 35,333,468 | 31,182,054 | ||
Admin Expenses | 0 | 6,068,000 | 22,011,000 | 26,862,000 | 24,727,000 | 20,242,000 | 16,774,000 | 21,897,000 | 7,050,006 | 15,474,797 | 15,785,695 | 7,562,171 | ||
Operating Profit | 0 | 6,638,000 | 8,810,000 | 2,132,000 | 3,667,000 | 6,379,000 | 10,562,000 | 7,200,000 | 7,921,392 | 21,447,905 | 19,547,773 | 23,619,883 | ||
Interest Payable | 0 | 434,000 | 117,000 | 206,000 | 339,000 | 518,000 | 557,000 | 676,000 | 1,000,401 | 1,164,923 | 1,218,199 | 2,704,460 | ||
Interest Receivable | 0 | 2,000 | 1,000 | 8,000 | 58,000 | 73,000 | 7,000 | 180,000 | 72,519 | 140,981 | 55,952 | 58,988 | ||
Pre-Tax Profit | 0 | 6,212,000 | 7,810,000 | 1,967,000 | 3,392,000 | 5,821,000 | 10,012,000 | 6,704,000 | 6,993,510 | 20,423,963 | 18,385,526 | 20,974,411 | ||
Tax | 0 | -1,294,000 | -1,776,000 | -739,000 | -804,000 | -1,066,000 | -2,433,000 | -1,496,000 | -1,665,703 | -5,150,250 | -5,137,911 | -2,768,185 | ||
Profit After Tax | 0 | 4,918,000 | 6,034,000 | 1,228,000 | 2,588,000 | 4,755,000 | 7,579,000 | 5,208,000 | 5,327,807 | 15,273,713 | 13,247,615 | 18,206,226 | ||
Dividends Paid | 0 | 86,250,000 | 0 | 0 | 0 | 11,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Retained Profit | 0 | -81,332,000 | 6,034,000 | 1,228,000 | 2,588,000 | -6,245,000 | 7,579,000 | 5,208,000 | 5,327,807 | 15,273,713 | 13,247,615 | 18,206,226 | ||
Employee Costs | 0 | 5,787,000 | 12,756,000 | 14,268,000 | 15,322,000 | 15,197,000 | 16,480,000 | 15,636,000 | 10,545,285 | 10,299,720 | 9,574,004 | 9,481,718 | ||
Number Of Employees | 321 | 362 | 411 | 437 | 446 | 447 | 439 | 302 | 300 | 293 | 297 | |||
EBITDA* | 0 | 9,402,000 | 14,615,000 | 8,684,000 | 11,308,000 | 14,313,000 | 18,063,000 | 14,005,000 | 8,472,584 | 27,304,025 | 25,156,881 | 29,145,093 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 59,734,000 | 64,265,000 | 76,812,000 | 71,043,000 | 77,442,000 | 78,404,000 | 74,462,828 | 78,976,122 | 81,014,124 | 83,384,055 |
Intangible Assets | 0 | 0 | 0 | 0 | 1,937,000 | 1,938,000 | 1,940,000 | 1,941,000 | 1,939,000 | 1,937,000 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 2,307,000 | 5,102,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,224,000 | 1,430,000 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 63,978,000 | 71,305,000 | 78,752,000 | 72,984,000 | 79,381,000 | 80,341,000 | 74,462,828 | 78,976,122 | 82,238,124 | 84,814,055 |
Stock & work in progress | 0 | 0 | 0 | 0 | 20,912,000 | 20,346,000 | 22,720,000 | 21,645,000 | 20,884,000 | 21,963,000 | 14,905,276 | 17,368,893 | 13,539,643 | 12,523,650 |
Trade Debtors | 0 | 0 | 0 | 0 | 1,239,000 | 3,196,000 | 1,351,000 | 3,390,000 | 13,733,000 | 14,468,000 | 3,906,133 | 21,965,366 | 17,642,878 | 13,361,297 |
Group Debtors | 299,000 | 299,000 | 299,000 | 299,000 | 22,917,000 | 10,094,000 | 14,987,000 | 20,956,000 | 16,484,000 | 21,387,000 | 30,466,732 | 11,986,821 | 5,675,141 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 570,000 | 702,000 | 841,000 | 1,136,000 | 1,030,000 | 1,551,000 | 68,876 | 93,074 | 269,199 | 33,560 |
Cash | 0 | 0 | 0 | 0 | 8,105,000 | 1,522,000 | 1,201,000 | 741,000 | 4,558,000 | 662,000 | 1,034,560 | 6,139,672 | 2,686,012 | 3,203,547 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 299,000 | 299,000 | 299,000 | 299,000 | 53,743,000 | 35,860,000 | 41,100,000 | 47,868,000 | 56,689,000 | 60,031,000 | 50,381,577 | 57,553,826 | 39,812,873 | 29,122,054 |
total assets | 299,000 | 299,000 | 299,000 | 299,000 | 117,721,000 | 107,165,000 | 119,852,000 | 120,852,000 | 136,070,000 | 140,372,000 | 124,844,405 | 136,529,948 | 122,050,997 | 113,936,109 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 3,232,000 | 564,000 | 0 | 0 | 0 | 1,106,772 | 2,039,775 | 6,818,843 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 7,902,000 | 7,737,000 | 7,560,000 | 6,580,000 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 15,675,000 | 12,000,000 | 14,281,000 | 8,435,000 | 7,056,000 | 7,587,000 | 2,797,418 | 7,482,058 | 5,211,586 | 5,258,071 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 8,873,000 | 7,688,000 | 9,158,000 | 12,841,000 | 7,703,000 | 8,520,000 | 2,267,400 | 4,318,853 | 2,563,485 | 313,006 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 6,000 | 422,000 | 778,000 | 682,000 | 6,423,171 | 5,596,943 | 8,863,351 | 7,669,508 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 4,167,000 | 3,066,000 | 3,552,000 | 3,771,000 | 10,540,000 | 11,006,000 | 6,362,008 | 8,711,364 | 5,925,383 | 5,325,050 |
total current liabilities | 0 | 0 | 0 | 0 | 28,715,000 | 22,754,000 | 38,131,000 | 33,770,000 | 33,637,000 | 34,375,000 | 17,849,997 | 27,215,990 | 24,603,580 | 25,384,478 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,980,000 | 16,155,000 | 26,825,000 | 31,771,593 | 38,255,368 | 41,004,818 | 50,011,564 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,941,434 | 5,408,760 | 5,876,087 | 6,343,414 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 3,072,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 5,230,000 | 6,209,000 | 4,123,000 | 3,627,000 | 4,247,000 | 4,252,000 | 5,042,986 | 5,739,242 | 5,929,637 | 807,393 |
total long term liabilities | 0 | 0 | 0 | 0 | 5,230,000 | 6,209,000 | 7,195,000 | 11,607,000 | 20,402,000 | 31,077,000 | 41,756,013 | 49,403,370 | 52,810,542 | 57,162,371 |
total liabilities | 0 | 0 | 0 | 0 | 33,945,000 | 28,963,000 | 45,326,000 | 45,377,000 | 54,039,000 | 65,452,000 | 59,606,010 | 76,619,360 | 77,414,122 | 82,546,849 |
net assets | 299,000 | 299,000 | 299,000 | 299,000 | 83,776,000 | 78,202,000 | 74,526,000 | 75,475,000 | 82,031,000 | 74,920,000 | 65,238,395 | 59,910,588 | 44,636,875 | 31,389,260 |
total shareholders funds | 299,000 | 299,000 | 299,000 | 299,000 | 83,776,000 | 78,202,000 | 74,526,000 | 75,475,000 | 82,031,000 | 74,920,000 | 65,238,395 | 59,910,588 | 44,636,875 | 31,389,260 |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | 0 | 6,638,000 | 8,810,000 | 2,132,000 | 3,667,000 | 6,379,000 | 10,562,000 | 7,200,000 | 7,921,392 | 21,447,905 | 19,547,773 | 23,619,883 | ||
Depreciation | 0 | 0 | 0 | 2,764,000 | 5,804,000 | 6,550,000 | 7,638,000 | 7,932,000 | 7,499,000 | 6,605,000 | 551,192 | 5,856,120 | 5,609,108 | 5,525,210 |
Amortisation | 0 | 0 | 0 | 0 | 1,000 | 2,000 | 3,000 | 2,000 | 2,000 | 200,000 | 0 | 0 | 0 | 0 |
Tax | 0 | -1,294,000 | -1,776,000 | -739,000 | -804,000 | -1,066,000 | -2,433,000 | -1,496,000 | -1,665,703 | -5,150,250 | -5,137,911 | -2,768,185 | ||
Stock | 0 | 0 | 0 | -20,912,000 | 566,000 | -2,374,000 | 1,075,000 | 761,000 | -1,079,000 | 7,057,724 | -2,463,617 | 3,829,250 | 1,015,993 | 12,523,650 |
Debtors | 0 | 0 | 0 | -24,427,000 | 10,734,000 | -3,187,000 | -8,303,000 | -5,765,000 | -6,159,000 | 2,964,259 | 396,480 | 9,234,043 | 9,986,361 | 14,824,857 |
Creditors | 0 | 0 | 0 | -15,675,000 | 3,675,000 | -2,281,000 | 5,846,000 | 1,379,000 | -531,000 | 4,789,582 | -4,684,640 | 2,270,472 | -46,485 | 5,258,071 |
Accruals and Deferred Income | 0 | 0 | 0 | -4,167,000 | 1,101,000 | -486,000 | -219,000 | -6,769,000 | -466,000 | -297,442 | -2,816,682 | 2,318,654 | 133,006 | 11,668,464 |
Deferred Taxes & Provisions | 0 | 0 | 0 | -5,230,000 | -979,000 | 2,086,000 | 496,000 | -620,000 | -5,000 | -790,986 | -696,256 | -190,395 | 5,122,244 | 807,393 |
Cash flow from operations | 0 | 28,375,000 | 5,336,000 | 12,825,000 | 23,855,000 | 12,241,000 | 21,866,000 | 6,188,171 | 676,440 | 13,489,213 | 14,225,381 | 16,762,329 | ||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | -2,307,000 | -2,795,000 | 5,102,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | -7,902,000 | 165,000 | 177,000 | 980,000 | 6,580,000 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | -8,873,000 | 1,185,000 | -1,470,000 | -3,683,000 | 5,138,000 | -817,000 | 6,252,600 | -2,051,453 | 1,755,368 | 2,250,479 | 313,006 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | -6,000 | -416,000 | -356,000 | 96,000 | -5,741,171 | 826,228 | -3,266,408 | 1,193,843 | 7,669,508 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | -7,980,000 | -8,175,000 | -10,670,000 | -4,946,593 | -6,483,775 | -2,749,450 | -9,006,746 | 50,011,564 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | -3,072,000 | 3,072,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | 0 | -432,000 | -116,000 | -198,000 | -281,000 | -445,000 | -550,000 | -496,000 | -927,882 | -1,023,942 | -1,162,247 | -2,645,472 | ||
cash flow from financing | 0 | -11,450,000 | 609,000 | -10,200,000 | -12,660,000 | -3,972,000 | -11,429,000 | 6,122,441 | -8,636,882 | -5,284,432 | -6,724,671 | 68,531,640 | ||
cash and cash equivalents | ||||||||||||||
cash | 0 | 0 | 0 | -8,105,000 | 6,583,000 | 321,000 | 460,000 | -3,817,000 | 3,896,000 | -372,560 | -5,105,112 | 3,453,660 | -517,535 | 3,203,547 |
overdraft | 0 | 0 | 0 | 0 | 0 | -3,232,000 | 2,668,000 | 564,000 | 0 | 0 | -1,106,772 | -933,003 | -4,779,068 | 6,818,843 |
change in cash | 0 | 0 | 0 | -8,105,000 | 6,583,000 | 3,553,000 | -2,208,000 | -4,381,000 | 3,896,000 | -372,560 | -3,998,340 | 4,386,663 | 4,261,533 | -3,615,296 |
intertissue limited Credit Report and Business Information
Intertissue Limited Competitor Analysis
![competitor_analysis_table_img](/assets/images/competitor_analysis_table.png)
Perform a competitor analysis for intertissue limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
intertissue limited Ownership
INTERTISSUE LIMITED group structure
Intertissue Limited has no subsidiary companies.
Ultimate parent company
SOFIDEL SPA
#0047462
1 parent
INTERTISSUE LIMITED
04537324
intertissue limited directors
Intertissue Limited currently has 2 directors. The longest serving directors include Mr Luigi Lazzareschi (Sep 2002) and Mr Edilio Stefani (Jan 2021).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Luigi Lazzareschi | 61 years | Sep 2002 | - | Director | |
Mr Edilio Stefani | Wales | 64 years | Jan 2021 | - | Director |
P&L
December 2022turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
299k
0%
total assets
299k
0%
cash
0
0%
net assets
Total assets minus all liabilities
intertissue limited company details
company number
04537324
Type
Private limited with Share Capital
industry
17120 - Manufacture of paper and paperboard
incorporation date
September 2002
age
22
accounts
Dormant
ultimate parent company
previous names
N/A
incorporated
UK
address
brunel way baglan energy park, briton ferry, neath, SA11 2FP
last accounts submitted
December 2022
intertissue limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to intertissue limited. Currently there are 1 open charges and 2 have been satisfied in the past.
![charges](/assets/images/company_charges.png)
intertissue limited Companies House Filings - See Documents
date | description | view/download |
---|